ADOR Diagnostics

ADOR Diagnostics is an in-vitro diagnostic (IVD) company that develops and manufactures multiplex molecular diagnostic solutions for rapid diagnosis of infectious diseases and othe

r medical conditions at the point of care and near-patient settings. Founded in 2015 as a joint venture between Italian company Adaltis S.R.L. and Dutch company Gamida B.V., the company is headquartered in Guidonia Montecelio, Rome, Italy, with operations and research and development in Israel and Italy. The core product is the NATlab system, a syndromic multiplex molecular diagnostic platform that provides fully automated, sample-to-answer results within 30 to 60 minutes for up to 100 multiplexed targets per sample. This modular analyzer is designed for rapid and accurate diagnostics, including the detection of antibiotic resistance markers, allowing healthcare providers to prescribe the correct treatment immediately. ADOR Diagnostics serves small to mid-sized laboratories, doctor offices, point-of-care testing sites, and specific hospital settings, including rural labs and mobile care units. The company is privately held and has raised significant funding to support its mission of enhancing laboratory diagnostics worldwide.